Search

Search Constraints

You searched for: Date 2022 Author/Creator Papi, Alberto

Search Results

2. Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline. (October 2022)

3. Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate‐to‐severe type 2 asthma. Issue 1 (9th August 2022)

5. Effects of anti‐IL5 biological treatments on blood IgE levels in severe asthmatic patients: A real‐life multicentre study (BIONIGE). Issue 4 (7th April 2022)

6. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations. Issue 5 (5th May 2022)

7. European Respiratory Society guidelines for the diagnosis of asthma in adults. Issue 3 (1st September 2022)

8. Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study. (August 2022)